OXYBUTYNINE BIOGARAN 5 mg, scored tablet 60 tablets, CIP 3400930061107
Active ingredients: Oxybutynin chloride
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet60 tablets, CIP 3400930061107orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OXYBUTYNINE BIOGARAN 5 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 60 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63309558CIP73006110CIP133400930061107Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'OXYBUTYNINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.